mechanisms of lung tumorigenesis by mutant egfr
Published 6 years ago • 165 plays • Length 24:42Download video MP4
Download video MP3
Similar videos
-
58:47
15 years of advances in egfr mutant lung cancer
-
44:45
yale cancer center grand rounds/john murren lecture
-
27:37
next generation egfr inhibitors for mutations and disease
-
24:58
strategies to prevent and overcome resistance to egfr-directed therapies in lung cancer
-
55:38
novel therapy for lung cancer: from targeted therapy to immuno-therapy and back again!
-
2:20
dr. liu on resistance mechanisms in egfr-mutant lung cancer
-
21:09
mechanisms of resistance to egfr tki and new treatment strategies
-
5:46
resistance mechanisms in egfr nsclc
-
4:32
resistance mechanisms in egfr-positive nsclc
-
3:34
repeat biopsy in lung cancer patients with egfr mutation
-
8:37
egfr mechanisms of resistance
-
19:09
targeted therapy for lung cancer
-
20:35
tki-resistant egfr-mutant nsclc
-
2:10
dr. lynch accepts his "giants of cancer care" award
-
5:52
mechanisms of osimertinib resistance in aura 3
-
45:12
the molecular tumor board: best practices for managing primary and acquired egfr tki resistance
-
19:53
managing progression in egfr-mutant nsclc patients: potential impact of 2nd and 3rd generation tkis?
-
45:43
egfr mutant lung cancer: 2013 update
-
1:49
dr. roy herbst | yale cancer center | asco 2020 osimertinib/adaura trial results